|
NUDT12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.140600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.020600E-03 |
| Normal-vs-Stage2 |
4.397000E-01 |
| Normal-vs-Stage3 |
5.423300E-04 |
| Normal-vs-Stage4 |
8.422100E-04 |
| Stage1-vs-Stage2 |
1.152230E-01 |
| Stage1-vs-Stage3 |
1.030040E-01 |
| Stage1-vs-Stage4 |
1.397240E-01 |
| Stage2-vs-Stage3 |
2.181700E-02 |
| Stage2-vs-Stage4 |
2.916000E-02 |
| Stage3-vs-Stage4 |
8.576600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.150000E-04 |
| Normal-vs-AfricanAmerican |
7.949800E-02 |
| Normal-vs-Asian |
1.525860E-02 |
| Caucasian-vs-AfricanAmerican |
6.652400E-01 |
| Caucasian-vs-Asian |
5.459200E-01 |
| AfricanAmerican-vs-Asian |
9.965600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.381500E-04 |
| Normal-vs-Female |
6.117000E-03 |
| Male-vs-Female |
1.179380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.040280E-02 |
| Normal-vs-Age(41-60Yrs) |
5.218200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.698700E-03 |
| Normal-vs-Age(81-100Yrs) |
6.516400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.783200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.501000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.308590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.930600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.727900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.369000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.174430E-02 |
| Classical-VS-Follicular |
9.760500E-04 |
| Classical-VS-Other |
7.005600E-01 |
| Classical-VS-Normal |
7.950400E-04 |
| Tall-VS-Follicular |
1.56972999999505E-05 |
| Tall-VS-Other |
9.230200E-02 |
| Tall-VS-Normal |
3.64190000000653E-05 |
| Follicular-VS-Other |
4.533200E-01 |
| Follicular-VS-Normal |
8.226800E-01 |
| Other-VS-Normal |
3.165600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.557700E-02 |
| Normal-vs-N1 |
1.316000E-03 |
| N0-vs-N1 |
1.233050E-01 |
|
|
